Filing Details
Arcadia Biosciences, Inc. (NASDAQ:RKDA) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:RKDA
Arcadia Biosciences, Inc. (RKDA) Reports Material Event to SEC
Filing Details Arcadia Biosciences, Inc. (NASDAQ:RKDA) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market Context…
Market Context
Arcadia Biosciences, Inc.'s stock currently trades at $0.73 with a market capitalization of $5.1M. The Basic Materials company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Arcadia Biosciences, Inc.'s stock.
All SEC filings for Arcadia Biosciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RKDA Stock Page
Frequently Asked Questions
Where can I read RKDA's SEC filings?
Browse all filings on our RKDA SEC filings page.
What types of SEC filings does Arcadia Biosciences, Inc. file?
Public companies like Arcadia Biosciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.